Latest BML Capital Management, LLC Stock Portfolio

$176Million | No. of Holdings #15

BML Capital Management, LLC Performance

2026 Q2+12.77%

YTD+34.62%

2025-8.75%

About BML Capital Management, LLC and 13F Hedge Fund Stock Holdings

On 2026-08-07, the fund reported it's updated stock portfolio. In the 13F Holdings report, BML Capital Management, LLC reported an equity portfolio of $176.1 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of BML Capital Management, LLC are ACRS, AVIR, . The fund has invested 36% of it's portfolio in ACLARIS THERAPEUTICS INC and 18.4% of portfolio in ATEA PHARMACEUTICALS INC. <br><br> The fund managers got completely rid off KEZAR LIFE SCIENCES INC (KZR) stocks. They significantly reduced their stock positions in ORAMED PHARMACEUTICALS INC (ORMP), ACLARIS THERAPEUTICS INC (ACRS) and ATEA PHARMACEUTICALS INC (AVIR). BML Capital Management, LLC opened new stock positions in ENGENE THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to KRAFT HEINZ CO (KHC), CONNECT BIOPHARMA HLDGS LTD and OUTSET MED INC (OM).

BML Capital Management, LLC Equity Portfolio Value

Last Reported on: 07 Aug, 2026

$176Million

as of Aug 07, 2026

BML Capital Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that BML Capital Management, LLC made a return of 12.77% in the last quarter. In trailing 12 months, it's portfolio return was 48.37%.

Performance
S&P 500

New Buys

Ticker	$ Bought
engene therapeutics inc	11,538,900

New stocks bought by BML Capital Management, LLC

Additions

Ticker	% Inc.
kraft heinz co	272
connect biopharma hldgs ltd	40.21
outset med inc	32.46
carmax inc	11.29
pmv pharmaceuticals inc	0.19

Additions to existing portfolio by BML Capital Management, LLC

Reductions

Ticker	% Reduced
oramed pharmaceuticals inc	-72.65
aclaris therapeutics inc	-15.96
atea pharmaceuticals inc	-1.51

BML Capital Management, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
kezar life sciences inc	-5,348,240

BML Capital Management, LLC got rid off the above stocks

Sector Distribution

BML Capital Management, LLC has about 73.2% of it's holdings in Healthcare sector.

Healthcare
Consumer Cyclical
Consumer Defensive
Others

Sector	%
Healthcare	73.2
Consumer Cyclical	10.4
Consumer Defensive	9.1
Others	7.4

Market Cap. Distribution

BML Capital Management, LLC has about 9.1% of it's portfolio invested in the large-cap and mega-cap stocks.

SMALL-CAP
MICRO-CAP
LARGE-CAP
UNALLOCATED
MID-CAP
NANO-CAP

Category	%
SMALL-CAP	56
MICRO-CAP	19.5
LARGE-CAP	9.1
UNALLOCATED	7.4
MID-CAP	5.2
NANO-CAP	2.8

Stocks belong to which Index?

About 87.4% of the stocks held by BML Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

RUSSELL 2000
S&P 500
Others

Index	%
RUSSELL 2000	73.1
S&P 500	14.3
Others	12.6

Top 5 Winners (%)		%
ACRS	aclaris therapeutics inc	37.8 %
ORMP	oramed pharmaceuticals inc	26.4 %
KMX	carmax inc	25.5 %
IKNA	imagenebio inc	18.0 %
OM	outset med inc	10.8 %

Top 5 Winners ($)		$
ACRS	aclaris therapeutics inc	20.2 M
ORMP	oramed pharmaceuticals inc	2.8 M
KMX	carmax inc	1.9 M
OM	outset med inc	1.1 M
PMVP	pmv pharmaceuticals inc	0.5 M

Top 5 Losers (%)		%
AVIR	atea pharmaceuticals inc	-13.5 %
PLRX	pliant therapeutics inc	-9.5 %
	connect biopharma hldgs ltd	-8.0 %
TIL	instil bio inc	-6.7 %

Top 5 Losers ($)		$
AVIR	atea pharmaceuticals inc	-5.1 M
TIL	instil bio inc	-0.4 M
PLRX	pliant therapeutics inc	-0.2 M
	connect biopharma hldgs ltd	-0.1 M

BML Capital Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BML Capital Management, LLC

BML Capital Management, LLC has 15 stocks in it's portfolio. About 93.3% of the portfolio is in top 10 stocks. AVIR proved to be the most loss making stock for the portfolio. ACRS was the most profitable stock for BML Capital Management, LLC last quarter.

$175.10MTotal Value

16.00Positions

07 Aug, 2026Last Reported

Current holdings of Current Stock Holdings of BML Capital Management, LLC, last reported on 07 Aug, 2026. Select a row with a linked ticker to view its historical trend.
Holdingsorted ascending	% Portfolio	Shares Held	$ Value	% Change
ACRS Aclaris Therapeutics Inc Aclaris Therapeutics IncACRS BML Capital Management, LLC's holding in Aclaris Therapeutics Inc over time	35.98%	11,975,000	$63.35M 35.98%	decreased 15.96 percentreduced

AVIR Atea Pharmaceuticals Inc Atea Pharmaceuticals IncAVIR BML Capital Management, LLC's holding in Atea Pharmaceuticals Inc over time	18.36%	6,952,330	$32.33M 18.36%	decreased 1.51 percentreduced

IKNA Imagenebio Inc Imagenebio IncIKNA BML Capital Management, LLC's holding in Imagenebio Inc over time	0.67%	200,730	$1.18M 0.67%	unchanged 0 percentunchanged

JANX Janux Therapeutics Inc Janux Therapeutics IncJANX BML Capital Management, LLC's holding in Janux Therapeutics Inc over time	1.35%	154,961	$2.38M 1.35%	unchanged 0 percentunchanged

KHC Kraft Heinz Co Kraft Heinz CoKHC BML Capital Management, LLC's holding in Kraft Heinz Co over time	6.24%	465,000	$10.98M 6.24%	increased 272 percentadded

KMX Carmax Inc Carmax IncKMX BML Capital Management, LLC's holding in Carmax Inc over time	5.18%	172,500	$9.12M 5.18%	increased 11.29 percentadded

KZR Kezar Life Sciences Inc Kezar Life Sciences IncKZR BML Capital Management, LLC's holding in Kezar Life Sciences Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

OM Outset Med Inc Outset Med IncOM BML Capital Management, LLC's holding in Outset Med Inc over time	6.18%	2,519,700	$10.89M 6.18%	increased 32.46 percentadded

ORMP Oramed Pharmaceuticals Inc Oramed Pharmaceuticals IncORMP BML Capital Management, LLC's holding in Oramed Pharmaceuticals Inc over time	2.37%	866,269	$4.17M 2.37%	decreased 72.65 percentreduced

PLRX Pliant Therapeutics Inc Pliant Therapeutics IncPLRX BML Capital Management, LLC's holding in Pliant Therapeutics Inc over time	1%	1,546,140	$1.76M 1%	unchanged 0 percentunchanged

PMVP Pmv Pharmaceuticals Inc Pmv Pharmaceuticals IncPMVP BML Capital Management, LLC's holding in Pmv Pharmaceuticals Inc over time	4.06%	5,330,000	$7.14M 4.06%	increased 0.19 percentadded

TGT Target Corp Target CorpTGT BML Capital Management, LLC's holding in Target Corp over time	2.78%	37,500	$4.90M 2.78%	unchanged 0 percentunchanged

TIL Instil Bio Inc Instil Bio IncTIL BML Capital Management, LLC's holding in Instil Bio Inc over time	2.82%	645,600	$4.96M 2.82%	unchanged 0 percentunchanged

TLYS Tillys Inc Tillys IncTLYS BML Capital Management, LLC's holding in Tillys Inc over time	5.13%	2,150,000	$9.03M 5.13%	unchanged 0 percentunchanged

Com A Engene Therapeutics Inc Engene Therapeutics Inc BML Capital Management, LLC's holding in Engene Therapeutics Inc over time	6.55%	6,669,910	$11.54M 6.55%	new position

Shs Connect Biopharma Hldgs Ltd Connect Biopharma Hldgs Ltd BML Capital Management, LLC's holding in Connect Biopharma Hldgs Ltd over time	0.78%	573,287	$1.36M 0.78%	increased 40.21 percentadded